key: cord-0994276-oqt9uw1e
authors: Özdemir, Öner; Yılmaz, Emine A.; Engin, Muhammet Mesut N.
title: An infant with COVID‐19 presenting with acute urticaria and angioedema
date: 2021-07-18
journal: Int J Dermatol
DOI: 10.1111/ijd.15782
sha: 51d59be213d4c6ca69decfd6aefb351d23e55fff
doc_id: 994276
cord_uid: oqt9uw1e

nan

reported in children, it has been reported that exanthema and mucocutaneous findings which are a criterion of Kawasaki-like or multisystem inflammatory syndrome in children (MIS-C), have been detected. 1 Papular, urticarial rashes, and purpuric lesions have been associated with COVID-19 infection as uncommon symptoms. 2 Acute urticaria/angioedema characterized by epidermal and/or subdermal swelling lasting less than 6 weeks can often be triggered by upper respiratory infections during childhood. Until recently, urticarial rash associated with COVID-19 has been described in especially adult patients, but the number reported in children is very few. As a result of three metaanalyses published, in the pediatric population, symptoms such as runny nose and nasal congestion are observed at a rate of 7-20%, while skin rash has been reported as less than 1%. [3] [4] [5] Here, we want to present an infant who presented with acute urticarial rash with angioedema who was diagnosed with COVID-19, which has been reported much less frequently.

A 12-month-old healthy girl presented to the outside hospital 3 days prior because of itchy skin rash (urticaria) and eye edema (angioedema) that started on the trunk and spread to the whole body (Figs. 1 and 2). She was admitted to our hospital when her skin rash continued despite oral antihistaminic treatments and intramuscular methylprednisolone treatment given at an external center for 3 days. In the physical examination of the patient who was hospitalized with the prediagnosis of acute urticaria, resistant to therapy, there was no additional positive physical examination finding, except for erythematous and edematous rashes on the skin that lasted for 3 days. In her history, it was learned that there was a fever of 38°C for 1 day in the beginning of the rash but had disappeared with an antipyretic therapy. It was learned that there was no diarrhea, fatigue, anorexia, cough, or respiratory distress. The patient had no contact with a known COVID-19 patient. There was no previous drug or food allergy or urticaria in her medical history.

There was no history of allergy or atopy in the medical history of the family. When the laboratory examinations of the patient were performed, the COVID-19 PCR result was positive, and the patient was then followed up in the COVID-19 inpatient service. D-dimer and C-reactive protein elevation was present ( With this presentation, when acute urticaria and/or angioedema is encountered and rarely occurs in the patient, it is of great importance to bring the COVID-19 viral infection to mind and to narrow the contact circle and to treat the disease. 

COVID-19 and multisystem inflammatory syndrome in children and adolescents

Angioedema and COVID-19: a new dermatological manifestation?

Acute urticaria as the initial presentation of COVID-19 in a pediatric patient

Sick-Samuels AC. Acute COVID-19 and multisystem inflammatory syndrome in children

Acute urticaria preceding other COVID-19-associated manifestations-A case report

Funding source: None. doi: 10.1111/ijd.15782